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How does insurance expansion affect the rate of thyroidectomy for treating thyroid cancer?
Findings
In this study using difference-in-differences models, the 2006 Massachusetts health care reform was
associated with a 26% increased rate of thyroidectomy for treating thyroid cancer and a 21% increased rate
of neck dissection among patients with cancer compared with control states.
Meaning
In Massachusetts, the expansion of health care results in an increased treatment of thyroid cancer.
Abstract
Importance
To our knowledge, thyroid cancer incidence is increasing faster than any other cancer type and is currently
the fifth most common cancer among women. While this rise is likely multifactorial, there has been scarce
consideration of the effect of insurance statuses on the treatment of thyroid cancer.
Objective
We evaluate the association of insurance expansion with thyroid cancer treatment using the 2006
Massachusetts health reform, which serves as a unique natural experiment.
Design, Setting, and Participants
We used the Agency for Healthcare Research and Quality State Inpatient Databases to identify patients
with government-subsidized or self-pay insurance or private insurance who were admitted to a hospital
with thyroid cancer and underwent a thyroidectomy between 2001 and 2011 in Massachusetts (n = 8534)
and 3 control states (n = 48 047). Difference-in-differences models were used to evaluate an association
between the 2006 Massachusetts health care reform and thyroid cancer treatment, and participants were
controlled for age, sex, comorbidities, and secular trends.
Main Outcomes and Measures
Change in the thyroidectomy rate for thyroid cancer treatment was the primary outcome evaluated.
Results
The Massachusetts cohort consisted of 6443 women (75.5%) and 2091 men (24.5%), of whom 6388
(79.6%) were white, 391 (4.9%) were black, 527 (6.6%) were Hispanic, 424 (5.3%) were Asian/Pacific
Islander, 63 (0.8%) were Native American, and 228 (2.8%) were other. The participants from control states
included 36 818 women (76.6%) and 11 229 men (23.4%), of whom 30 432 (65.5%) were white, 3818
(8.2%) were black, 6462 (13.9%) were Hispanic, 2591 (5.6%) were Asian/Pacific Islander, 211 (0.5%)
were Native American, and 2947 (6.3%) were other. Before the 2006 Massachusetts insurance expansion,
patients with government-subsidized or self-pay insurance had lower thyroidectomy rates for thyroid
cancer in Massachusetts and the control states compared with patients with private insurance. The
Massachusetts insurance expansion was associated with a 26% increased rate of undergoing a
thyroidectomy (incident rate ratio, 1.26; 95% CI, 1.04-1.52; P = .02) and a 22% increased rate of neck
dissection (incident rate ratio, 1.22; 95% CI, 1.07-1.37; P = .002) for treating cancer compared with control
states.
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The 2006 Massachusetts health reform, which is a model for the Affordable Care Act, was associated with
a 26% increased rate of thyroidectomy for treating thyroid cancer. Our study suggests that insurance
expansion may be associated with increased access to the surgical management of thyroid cancer. Further
studies need to be conducted to evaluate the effect of healthcare expansion at a national level.
Introduction
The incidence of thyroid cancer has been increasing by 5% each year over the last decade. By 2019, it is
projected to be the third most common cancer among women younger than 45 years. While there has been
an increase in the incidence rate of thyroid cancer, 5-year survival remains above 98%. As life expectancy
and the incidence of thyroid cancer rises in the United States, the management and treatment of survivors
of thyroid cancer may have a significant economic burden on the US healthcare system. An estimated $1.6
billion has been cumulatively spent on the treatment of thyroid cancer care since 1985. Forty-one percent
of those costs were attributed to diagnosis, surgery, and adjuvant therapy for new thyroid cancer cases and
27% were attributed to the surveillance of survivors. While the rise in thyroid cancer incidence is likely
multifactorial, including the possibility of overdiagnosis, to our knowledge there have been few research
studies investigating how insurance expansion influences the diagnosis and treatment of thyroid cancer.
In 2006, Massachusetts passed health care reform legislation that expanded Medicaid, created new
subsidized insurance programs for those ineligible for Medicaid, and extended young adult eligibility on
parental plans until the age of 26 years. Since then, Massachusetts has seen increased coverage to more
than 97% of residents, with most newly insured people enrolling in either Medicaid or the newly created,
subsidized Commonwealth Care insurance (eFigure 1 in the Supplement). Nonwhite residents had
particularly striking gains in coverage, with uninsured rates among black and Hispanic residents decreasing
from approximately 18% to fewer than 5% (eFigure 2 in the Supplement). Previous studies found that this
expansion is associated with the increased use of discretionary and acute surgical procedures and increased
rates of undergoing resection for other malignancies. The Massachusetts legislation was a framework for
the Affordable Care Act, which has provided an estimated 16.9 million Americans insurance coverage. To
our knowledge, the effect of insurance expansion on the surgical treatment of thyroid cancer has not been
investigated. We evaluated the association of insurance expansion with thyroid cancer treatment using the
2006 Massachusetts health reform, which serves as a unique natural experiment for the potential
implications of the Affordable Care Act. We hypothesized that insurance expansion was associated with
increased rates of surgical treatment among patients with government-subsidized and self-pay (GSSP)
insurance in Massachusetts compared with those in control states. Additionally, we hypothesized that
nonwhite patients, who disproportionately gained coverage, had greater increases in undergoing treatment
compared with white patients.
Methods
Study Design and Data
We identified a cohort of 56 581 inpatient admissions using the Hospital Cost and Utilization Project State
Inpatient Databases for Massachusetts, New Jersey, New York, and Florida between January 1, 2001, and
December 31, 2011. These administrative data are collected and maintained by public-private partnerships
that are supported by the Agency of Healthcare Research and Quality. The State Inpatient Databases
capture nearly all inpatient discharges in their respective states annually. Control states were selected based
on the completeness of the data and a similar availability of primary care and surgical services. We
included all nondisabled, nonelderly adult patients with thyroid cancer and all patients who were uninsured
or had coverage through Medicaid or Commonwealth Care (available in Massachusetts after 2006). This
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cohort, referred to as GSSP patients, is the primary group that was affected by the reform in Massachusetts
or by similar reforms in control states. Sensitivity analyses were performed on privately insured (PI)
patients to evaluate for secular trends within Massachusetts. Consistent with previously published studies,
admissions of patients with diagnoses of thyroid cancer were determined using the International
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes. Patients
younger than 18 years and patients who were 65 years or older were excluded from the primary analysis, as
the Massachusetts law did not directly affect these populations. Patients with Medicare coverage were also
excluded from the analysis, as the 2006 law was not intended to affect Medicare eligibility or benefits. The
study was deemed exempt from institutional review board approval because it was a retrospective review
using a database that did not have patient-specific data.
Outcomes
The primary outcome of the study was partial or total thyroidectomy for thyroid cancer treatment.
Secondary outcome of interests were neck dissections for thyroid cancer treatment. Thyroidectomy for
cancer treatment was defined as if the patient had thyroid cancer and a concurrent procedure code for
partial or total thyroidectomy (ICD-9-CM 06.2, 06.31, 06.39, 06.4, 06.50, 06.51, or 06.52). Neck dissection
for cancer treatment was defined as if the patient had thyroid cancer and a concurrent procedure code for
radical, unilateral, or bilateral neck dissection (ICD-9-CM 40.40, 40.41, or 40.42).
Risk Adjustment
Multivariable analyses were performed controlling for patient and system-level factors including patient
age, sex, race/ethnicity, comorbidities using the Elixhauser Comorbidity Index, hospital type, and secular
trends. Race/ethnicity was included as a covariate in analyses examining changes in outcomes for all GSSP
patients. To evaluate differential changes by race, cohorts were stratified as being either white or nonwhite
(black or Hispanic). Hospital type was classified as either a privately owned hospital with any number of
beds or location, not-for-profit rural hospitals with any number of beds, not-for-profit urban hospitals with
fewer than 300 beds, and not-for-profit urban hospitals with more than 300 beds. Additional analyses,
including hospital-level annual volume of thyroidectomies, did not significantly change our results. For
each model we used the Stata-derived cluster-correlated robust estimate of variance to account for
clustering within hospitals. We controlled for secular trends using a continuous, quarterly time variable
beginning in the first quarter of 2001 and ending with the fourth quarter of 2011.
The primary independent variable of interest was the intervention group (Massachusetts) vs the control
group (control states) before and after the 2006 reform. The prereform period was defined as any discharge
occurring from the first quarter of 2001 through the second quarter of 2006 when the Massachusetts law
was passed. The postreform period was defined as any discharge during or after the first quarter of 2008.
We omitted discharges between the third quarter of 2006 and fourth quarter of 2007, as this was a transition
period when different elements of the insurance expansion were going into effect. Previous studies suggest
that the most significant uptake in insurance coverage occurred after the individual mandate went into
effect in January 2008. However, sensitivity analyses including all discharges from 2001 through 2011 did
not change our results.
Statistical Analysis
Our primary analyses used difference-in-differences models to evaluate differential changes in outcomes
among GSSP patients in Massachusetts as compared with those in control states. Difference-in-differences
models identify changes in outcomes in a group exposed to a policy change compared with an unexposed
control group. We used a triple-interaction term between Massachusetts, GSSP, and a postreform variable
to evaluate for any differential change in Massachusetts after the implementation of reform compared with
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concurrent trends in control states. This triple-interaction term accounts for not only changes for GSSP in
control states but also among PI patients in Massachusetts. The subsequent coefficient represents the
independent change in outcomes for GSSP in Massachusetts attributable to the 2006 reform. We used
Poisson regression models to evaluate surgical interventions as count data and to estimate the incident rate
ratio (IRR) of undergoing thyroidectomy or neck dissections for thyroid cancer. The primary dependent
variables in these models were thyroidectomy or neck dissection. The population denominators for GSSP
and PI patients were determined using data available through the US Census Bureau. In the final risk-
adjusted models, the IRR represents the independent effect of the 2006 insurance expansion on
thyroidectomy or neck dissection rates among GSSP patients in Massachusetts.
To evaluate changes in thyroidectomy and neck dissections for cancer treatment by the race/ethnicity of
patients, we stratified GSSP patients by race/ethnicity and used a 2-way interaction term between
Massachusetts and the postreform period. Population denominators were determined using US Census
Bureau data. Additional models using a 3-way interaction term between Massachusetts, the postreform
period, and nonwhite race/ethnicity did not change our results. Data were analyzed using Stata software,
version 14 (StataCorp). All results were considered significant at P ≤ .05.
Results
Our cohort included 8534 admissions of patients with thyroid cancer in Massachusetts and 48 047
admissions in control states (Table 1). Patients in Massachusetts were similar to those in control states in
terms of age, sex, and comorbidities. However, patients in Massachusetts were more likely to be white and
less likely to be admitted to private hospitals. Before the reform, there was no differential trend in
undergoing a thyroidectomy between Massachusetts and control states among either GSSP (IRR, 1.01; 95%
CI, 0.99-1.03; P = .18) or PI patients (IRR, 1.00; 95% CI, 1.00-1.01; P = .33) (Figure 1). Similarly, there
was no differential preexpansion trend in undergoing a neck dissection between Massachusetts and control
states among GSSP (IRR, 1.00; 95% CI, 0.99-1.02; P = .74) or PI patients (IRR, 1.00; 95% CI 0.99-1.01; P 
= .65) (eFigure 3 in the Supplement).
The Massachusetts coverage expansion was associated with a 26% increased rate of undergoing a
thyroidectomy (IRR, 1.26; 95% CI, 1.04-1.52; P = .02) and a 22% increased rate of undergoing a neck
dissection (IRR, 1.22; 95% CI, 1.07-1.37; P = .002) among GSSP patients in Massachusetts (Table 2).
Sensitivity analyses with patients stratified by payer demonstrated the 2006 insurance expansion was
associated with a 27% increased rate of undergoing a thyroidectomy among GSSP patients in
Massachusetts (IRR, 1.27; 95% CI, 1.05-1.53; P = .02) but no significant change in thyroidectomy rates
among PI patients in Massachusetts (IRR, 1.01; 95% CI, 0.76-1.34; P = .97) relative to those in control
states. Similarly, stratified analyses for neck dissection insurance expansion was independently associated
with a 21% increased rate of undergoing a neck dissection among GSSP patients in Massachusetts (IRR,
1.21; 95% CI, 1.07-1.38; P = .003) with no change in the rate of undergoing a neck dissection among PI
patients in Massachusetts (IRR, 0.97; 95% CI, 0.78-1.22; P = .81) relative to those in control states.
Sensitivity analyses using all discharges during the study period, including the implementation period of
2006 quarter 3 through 2007 quarter 4, did not alter our findings.
Examining these trends further by race/ethnicity, we found that insurance expansion had a particularly
strong association with rates of undergoing procedures for nonwhite patients. Before the reform, nonwhite
and white patients had comparable rates of undergoing a thyroidectomy in Massachusetts and control states
(Figure 2). Stratified analyses found that the 2006 reform was associated with a 68% increased rate of
undergoing a thyroidectomy (IRR = 1.68; 95% CI, 1.24-2.29; P=.001) among nonwhite patients in
Massachusetts compared with concurrent trends among patients in control states (Table 3). White patients
in Massachusetts had an increased rate of undergoing a thyroidectomy that was not statistically significant
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(IRR, 1.22; 95% CI, 0.98-1.51; P = .07). Similarly, nonwhite and white patients had similar rates of
undergoing a neck dissection in Massachusetts and control states before the reform (eFigure 4 in the
Supplement). Analogous to thyroidectomy, the Massachusetts coverage expansion was associated with a
45% increased rate of undergoing neck dissections (IRR, 1.45; 95% CI, 1.12-1.87; P = .01) among
nonwhite patients compared with control states (Table 3). There was a nonsignificant increase (IRR, 1.16;
95% CI, 0.99-1.40; P = .07) in the rate of undergoing a neck dissection for white patients in Massachusetts
compared with the trend in control states. Sensitivity analyses using the triple-interaction term between
Massachusetts, nonwhite race/ethnicity, and the postreform period confirmed that the expansion was
associated with a statistically greater increased rate of undergoing a thyroidectomy (IRR, 1.66; 95% CI,
1.23-2.24; P = .001) and neck dissection (IRR, 1.44; 95% CI, 1.13-1.86; P = .004) among nonwhite patients
in Massachusetts.
Discussion
The incidence of thyroid cancer continues to rise across the country and considerable disparities in
diagnosis, management, and outcomes have been documented. Simultaneously, there is growing attention
to the potential overdiagnosis and treatments for thyroid cancer. To our knowledge, our study is the first to
evaluate the influence of insurance expansion on surgical procedures for thyroid cancer. We found that the
Massachusetts insurance expansion was associated with a 26% increased rate of thyroidectomy and a 22%
increased rate of neck dissections for thyroid cancer. The increased rate occurred disproportionately among
nonwhite patients, with a 68% increased rate of undergoing a thyroidectomy and 45% increased rate of
undergoing neck dissections among nonwhite patients compared with control states.
Although no studies to date to our knowledge have evaluated the effect of health care expansion on the
diagnosis and treatment of thyroid cancer, several studies evaluating other medical conditions have
suggested that increased insurance coverage is associated with the increased use of services. Early reports
on insurance expansion through the Affordable Care Act similarly report an increased use of services
among patients after gaining insurance coverage. The findings in this study are consistent with our previous
work showing a strong association between the 2006 Massachusetts reform and increased use of surgical
services, especially among nonwhite populations.
Our findings suggest that expanded insurance coverage has contributed to increased diagnoses and
interventions on thyroid cancer, most likely because of an increased access to care. Patients may be
presenting more readily to primary care clinicians and may be referred at a higher rate to specialists who
are more likely to intervene. While there are certainly benefits to expanding health insurance coverage,
including the diagnosis and treatment of cancer, there must also be thoughtful consideration to the
appropriateness of diagnostic and treatment modalities.
Increasing attention is being directed toward the most efficient and effective methods of managing thyroid
cancer. Previous reports suggest that the overdiagnosis of small, papillary thyroid carcinoma accounts for a
significant portion of the rising incidence of thyroid cancer. However, the increased incident rate of these
small cancers predates this study and is unlikely to have influenced our findings selectively for GSSP
patients in Massachusetts. The data used in this study do not provide adequate oncologic granularity to
determine pathologic diagnoses, stages of disease, or long-term outcomes. Therefore, it remains unclear
whether increased intervention, as seen after the insurance expansion in Massachusetts, will necessarily
translate into improved morbidity and prognosis.
The present study was not designed to explicitly examine the appropriateness of thyroidectomy for cancer.
Despite a disproportionate increase in thyroidectomy for cancer after insurance expansion, GSSP patients
in Massachusetts still had lower resection rates than privately insured patients in the state (eFigure 5 in the
Supplement). However, we cannot determine whether this gap in thyroidectomy rates represents a
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persistent disparity in care for GSSP patients, an overuse of surgery among PI patients, or some
combination of the two. The increased rates in Massachusetts, however, provide important insights into
potential changes to insurance expansion elsewhere in the country.
Limitations
We acknowledge several important limitations. First, the State Inpatient Databases are composed of
administrative data that are susceptible to coding errors. However, Healthcare Cost and Utilization Project
data have been used extensively in prior studies evaluating thyroid cancer. Furthermore, it is unlikely that
coding discrepancies would selectively and directionally lead to increased rates of thyroidectomy and neck
dissections among GSSP patients in Massachusetts without concordant changes among PI patients. Using
the State Inpatient Databases, we are unfortunately unable to identify the specific individuals that gained
insurance after the Massachusetts reform. We included a much broader population of individuals who were
potentially affected by insurance expansion before and after the reform in both Massachusetts and control
states. Consequently, we included many individuals in Massachusetts that were covered by Medicaid
before and after the reform. However, including these patients would dilute the measured effect of
insurance expansion rather than amplify findings.
Our analysis is also limited in capturing only inpatient surgical procedures. In recent years, more
thyroidectomies are performed in the outpatient setting. After examining data from the New York State
Ambulatory Surgery Database and State Inpatient Database, it was recently reported that approximately
17% of thyroidectomies were done in an ambulatory setting, although more than 90% of all Medicaid
patients had the procedure in an inpatient setting. Unfortunately, there is no Ambulatory Surgery Database
available in Massachusetts and we are unable to comment on outpatient procedures before and after the
2006 expansion.
Finally, Massachusetts was a unique health care environment even before the 2006 reform, with small
uninsured populations and a high concentration of health care professionals. Thus, the Massachusetts
experience may not be generalizable elsewhere in the country. An evaluation of parallel trends before the
reform reveals similar rates and trends between Massachusetts and control states before the expansion.
Other factors independent of insurance expansion, such as changes in the number of trained or practicing
endocrine surgeons in Massachusetts, could also have influenced rates after the reform. However, our
evaluation of trends among PI patients in Massachusetts, who were less directly affected by the 2006
reform, showed no significant change in outcomes after implementation. Collectively, these findings argue
against alternative factors between states or within Massachusetts driving the increased receipt of
thyroidectomy and neck dissections for thyroid cancer among GSSP patients after insurance expansion.
Nonetheless, given the unique aspects of Massachusetts, the control states used in this study may not fully
represent the counterfactual of Massachusetts without reform. While we are unable to fully overcome these
limitations with the data available, ongoing evaluation of states expanding insurance coverage through the
Affordable Care Act will provide much greater insights. As 19 remaining states consider whether to expand
Medicaid as a part of the Affordable Care Act, our findings provide important information about how such
an expansion may influence care delivery for thyroid cancer. Policy makers, researchers, and health
systems should continue to critically analyze the effects of ongoing policy changes on the accessibility and
equity of clinical care.
Conclusions
In this study, we report that the 2006 Massachusetts insurance expansion was associated with significant
increases in surgical intervention for thyroid cancer, specifically among nonwhite populations. Our findings
provide encouraging evidence that insurance coverage may help mitigate racial or socioeconomic
disparities while also raising questions concerning the relative appropriateness of the observed management
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of thyroid cancer, which deserves additional investigation.
Notes
Supplement.
eFigure 1. Trends in Insurance Coverage in Masschusetts.
eFigure 2. Trends in the Percentage of Massachusetts Population That Was Uninsured, by
Race/Ethnicity.
eFigure 3. Unadjusted Trends in Neck Dissection for Thyroid Cancer in Government
Subsidized/Self-pay Patients in Massachusetts and Control States.
eFigure 4. Unadjusted Trends in Neck Dissection for Cancer in Government Subsidized/Self-pay
Patients in Massachusetts and Control States, by Patient Race/Ethnicity.
eFigure 5. Unadjusted Trends in Thyroidectomy for Cancer in Massachusetts and Control States, by
Payer
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Table 1.
Demographic and Clinical Characteristics
Characteristic Massachusetts Control States
Thyroid cancer, No. 8534 48 047
Thyroidectomy, No. (%) 6627 (77.8) 30 349 (63.2)
Age, mean (SD) 44.5 (11.4) 44.8 (11.4)
Women, No. (%) 6443 (75.5) 36 818 (76.6)
Race/ethnicity, No. (%)
White 6388 (79.6) 30 432 (65.5)
Black 391 (4.9) 3818 (8.2)
Hispanic 527 (6.6) 6462 (13.9)
Asian/Pacific Islander 424 (5.3) 2591 (5.6)
Native American 63 (0.8) 211 (0.5)
Other 228 (2.8) 2947 (6.3)
Elixhauser Comorbidity Index, mean (SD) 0.9 (1.1) 0.9 (1.1)
Private insurance coverage, No. (%) 7332 (88.2) 39 444 (82.1)
Hospital type, No. (%)
Private 147 (1.7) 2845 (5.9)
NFP
Rural 65 (0.8) 399 (0.8)
Urban, <300 beds 1943 (22.8) 8544 (17.8)
Urban, >300 beds 6377 (74.7) 36 222 (75.5)
Abbreviation: NFP, not-for-profit.
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Figure 1.
Unadjusted Trends in Undergoing Thyroidectomy for Cancer Among Government-Subsidized/Self-pay Patients in
Massachusetts and Control States
The vertical line indicates the year of the Massachusetts health care reform.
Association of Insurance Expansion With Surgical Management of Thyro... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831462/?report=printable
12 of 15 7/30/2018, 3:15 PM
Table 2.
Effect of the Insurance Expansion in Massachusetts on Rates of Undergoing Thyroidectomy
and Neck Dissection for Cancer Among Government-Subsidized/Self-pay Patients
Procedure Rate Expansion Effect
Massachusetts Control States
Pre Post Diff Pre Post Diff Unadjusted Rate Change IRR P Value
Thyroidectomy 4.0 10.4 +6.4 4.4 6.0 +1.6 +4.8 1.26 .02
Neck dissection 4.5 11.2 +6.7 4.8 6.6 +2.2 +4.5 1.22 .002
Abbreviations: Diff, difference; IRR, incident rate ratio; Post, postreform; Pre, prereform.
Rate is surgical procedures per 100 000 residents per quarter.
Incident (surgical) rate ratio controlling for age, sex, comorbidities, race/ethnicity, hospital type and clustering, and





Association of Insurance Expansion With Surgical Management of Thyro... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831462/?report=printable
13 of 15 7/30/2018, 3:15 PM
Figure 2.
Unadjusted Trends in Undergoing Thyroidectomy for Cancer Among Government-Subsidized/Self-pay Patients in
Massachusetts and Control States, by Patient Race/Ethnicity
The vertical line indicates the year of the Massachusetts health care reform. MA, N indicates Massachusetts, nonwhite
patients; MA, W indicates Massachusetts, white patients; CS, W indicates control states, white patients; and CS, N
indicates control states, nonwhite patients.
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Table 3.
Effect of the Massachusetts Insurance Expansion on Rates of Undergoing Thyroidectomy and
Neck Dissection for Cancer by Patient Race/Ethnicity
Rate Expansion Effect
Massachusetts Control States
Pre Post Diff Pre Post Diff Unadjusted Rate Change IRR P Value
Thyroidectomy
White 3.4 7.7 +4.3 3.5 4.6 +1.1 +3.2 1.22 .07
Nonwhite 3.1 12.4 +9.3 3.5 4.1 +0.6 +8.7 1.68 .001
Neck Dissection
White 4.0 8.2 +4.2 3.9 5.1 +1.2 +3.0 1.16 .07
Nonwhite 3.3 13.7 +10.4 3.9 4.7 +0.8 +9.6 1.45 .01
Abbreviations: Diff, difference; IRR, incident rate ratio; Post, postreform; Pre, prereform.
Rate is surgical procedures per 100 000 residents per quarter.
Incident (surgical) Rate Ratio controlling for age, sex, comorbidities, race, hospital type and clustering, and secular
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